cisatracurium besylate
NDC 0781-3150, cisatracurium besylate, injection, from Sandoz Inc.
- Product NDC
- 0781-3150
- Status
- Listed
- Labeler
- Sandoz Inc
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200154
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CISATRACURIUM BESYLATE2 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0781-3150-95 | 00781315095 | 10 BOX in 1 CARTON (0781-3150-95) / 1 VIAL in 1 BOX (0781-3150-75) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/291a55dd-ab45-4660-b513-4ecb729eb051
Use it
Look up 0781-3150 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0781-3150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.